文献速递睡眠呼吸障碍

阻塞性睡眠呼吸暂停的表型亚型:精准医学的挑战与机遇

Phenotypic Subtypes of OSA: A Challenge and Opportunity for Precision Medicine.
PubMed 文献 · Chest · 2019-09-17

本文综述了近期聚类分析研究,指出OSA患者存在基于症状和多导睡眠图的异质性亚型,不同亚型对CPAP治疗的反应及心血管风险存在差异。文章强调表型亚型在精准医学中的潜在作用与局限,并呼吁将表型与临床结局关联、验证可重复性并纳入女性和种族多样人群。

要点

  • OSA管理目前采用一刀切模式,未考虑患者异质性。
  • 聚类分析可识别症状型(如过度嗜睡型、睡眠紊乱型)和多导睡眠图型亚型。
  • 不同亚型对CPAP症状改善和心血管风险的影响存在差异。

核心结论

  • OSA存在基于症状和多导睡眠图的表型亚型,可能推动精准医学发展。
  • 表型亚型在精准医学中的作用和局限需进一步评估。

研究设计与样本

  • 综述总结了近期睡眠呼吸暂停领域的聚类分析研究。

主要发现

  • 症状亚型如「过度嗜睡」和「睡眠紊乱」对CPAP症状和健康相关生活质量影响不同。
  • 多导睡眠图亚型按呼吸事件与低氧血症、觉醒或两者关联区分,心血管风险和疗效反应各异。

临床怎么用

  • 未来需将表型与临床相关结局关联,并开发工具对患者进行亚型分类以验证预后和治疗。

局限性

  • 表型可重复性需严格透明评估。
  • 研究需纳入女性和种族/民族多样人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Current strategies for the management of OSA reflect a one-size-fits-all approach. Diagnosis and severity of OSA are based on the apnea-hypopnea index and treatment initiated with CPAP, followed by trials of alternatives (eg, oral appliances) if CPAP "fails." This approach does not consider the heterogeneity of individuals with OSA, reflected by varying risk factors, pathophysiological causes, clinical manifestations, and consequences. Recently, studies using analytic approaches such as cluster analysis have taken advantage of this heterogeneity to identify OSA phenotypes, or subtypes of patients with unique characteristics, that may enable more personalized approaches to prognostication and treatment. Examples include symptom-based subtypes such as "excessively sleepy" and "disturbed sleep" with differing impact of CPAP on symptoms and health-related quality of life. Polysomnographic subtypes, distinguished by respiratory event association with hypoxemia, arousals, or both, exhibit varying risks of cardiovascular disease and response to therapy. This review summarizes the findings from recent cluster analysis studies in sleep apnea and synthesizes common themes to describe the potential role (and limitations) of phenotypic subtypes in precision medicine for OSA. It also highlights future directions, including linking of phenotypes to clinically relevant outcomes, rigorous and transparent assessment of phenotype reproducibility, and need for tools that categorize patients into subtypes, to prospectively validate phenotype-based prognostication and treatment approaches. Finally, we highlight the critical need to include women and more racially/ethnically diverse populations in this area of research if we are to leverage the heterogeneity of OSA to improve patient lives.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Zinchuk A, Yaggi HK. Phenotypic Subtypes of OSA: A Challenge and Opportunity for Precision Medicine. Chest. 2019. PMID: 31539538. doi:10.1016/j.chest.2019.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。